||Evaluation of the potential carcinogenicity of indo(1,2,3-cd)pyrene (193-39-5) /
||Syracuse Research Corp., NY. ;Environmental Monitoring and Services, Inc., Washington, DC.;Environmental Protection Agency, Washington, DC. Office of Health and Environmental Assessment.
|| U.S. Environmental Protection Agency, Office of Emergency and Remedial Response ;
||EPA/600/8-91/142; EPA-68-03-3112; EPA-68-03-3182; OHEA-C-073-117
Risk assessment ;
Public health ;
Hazardous materials ;
Dose-response relationships ;
CAS Registry No: 193-39-5
||Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy.
||15 pages ; 28 cm
||Indeno(1,2,3-cd)pyrene is a possible human carcinogen, classified as weight-of-evidence Group C under the EPA Guidelines for Carcinogen Risk Assessment. Evidence on potential carcinogenicity from animal studies is 'Limited', and the evidence from human studies is 'No Data'. Data available are inadequate for calculating a potency factor (F) and no quantitative inferences can be made. Indeno(1,2,3-cd)pyrene is, therefore, assigned to the median potency factor range and placed in potency group 2 under the CAG's methodology for evaluating potential carcinogens. Combining the weight-of-evidence group and the potency group, indeno(1,2,3-cd)pyrene is assigned a 'LOW' hazard ranking.
||Cover title. "June 1988." Includes bibliographical references. Microfiche.
||Washington, D.C. :
||Prepared in cooperation with Environmental Monitoring and Services, Inc., Washington, DC. Sponsored by Environmental Protection Agency, Washington, DC. Office of Health and Environmental Assessment.
|Corporate Au Added Ent
||United States. Environmental Protection Agency. Office of Health and Environmental Assessment. Carcinogen Assessment Group.
|PUB Date Free Form
||PC A03/MF A01
|OCLC Time Stamp
|OCLC Rec Leader
||01127nam 2200253Ka 45020